Development and Validation of Stability Indicating Uv and Rp-Hplc Method for the Estimation of Flupritine Maleate in Bulk and Formulations

INTRODUCTION

Flupritine acts as a centrally acting non opioid analgesic¹. Chemically it is amino pyridine derivative with the chemical name of ethyl 2-amino-6-[(4 fluorobenzyl) amino] pyridin-3-yl carbamate maleat². Flupritine was noted for its neuroprotective properties and also investigated for use in Creutzfeldt–Jakob disease, Alzheimer’s disease, and multiple sclerosis. Literature review reveals that various analytical methods like UV Spectrophotometry^3-4, HPLC^5-7 have been developed However no stability indicating UV methods are reported but one stability indicating HPLC method⁸ was reported for the estimation of flupritine maleate Hence, an attempt was made to develop simple, accurate and precise stability indicating UV and RP-HPLC methods for the estimation of flupritine maleate in pure and their marketed formulations.

 

Figure 1  Click here to View figure

 

EXPERIMENTAL

MATERIALS AND METHODS

LABINDIA-3000+ UV-Visible double beam spectrophotometer with a fixed slit width 1nm and 1cm matched quartz cells was used for all the spectral measurements.Alliance WATERS e 2695 HPLC with UV, VISIBLE-2489 & PDA-2998 Detector. All reagents used were of analytical reagent (AR) grade. HPLC grade methanol and water was used throughout analysis. Flupritine sample was kindly provided by Sun pharmaceuticals Ltd.

CHROMATOGRPHIC CONDITIONS AND MOBILE PHASE IN HPLC

Chromatographic separation was achieved on Agilent Eclipse C18, 150 x 4.6 mm, 5 m. Flow rate was maintained at 1.0 ml/min with 30°c column temperature.The detection was monitored at 246 nm and the run time was 8 minutes. The volume of injection loop was 10 µl prior to injection of the drug solution. To 1000ml of HPLC grade water 1 ml of orthophosphoric acid and 1 ml of TEA were added and the pH adjusted to 3 with dilute OPA solution. The mobile contains Buffer and Methanol in the ratio of 60:40%v/v, filtered through 0.45µ membrane filter and sonicated for 20 minutes to degas. Water and Methanol(50:50) was used as diluent.

OPTIMIZED CONDITIONS IN UV

Methanol is used as diluent. 250 nm was selected as detection wavelength.

PREPARATION OF SOLUTIONS IN HPLC

Preparation of standard solution

Accurately Weighed and transferred 10 mg of flupritine maleate working Standard into a 10 ml clean dry volumetric flask, and 7 ml of HPLC grade Water was added, sonicated for 5 minutes and make up to the final volume with diluent. (Fig.2)

 

Figure 2 Click here to View figure

 

Preparation of sample solution

20 tablets were weighed and crushed into powder, weight equivalent to 1 tablet was calculated. 5 tablets powder weight was transferred into a 200 mL volumetric flask, 150mL of diluent added and sonicated for 25 min, further the volume made up with diluent and filtered. From the filtered solution 4.0ml was pipetted out into a 100 ml volumetric flask and made up to 100ml with diluent. The % assay was found to be 100%.

PREPARATION OF SOLUTIONS IN UV

Preparation of standard solution

Accurately weigh and transfer 10 mg of flupritine Working standard into a 10 mL volumetric flask add about 7 mL of Diluent and sonicated to dissolve it completely and madethe volume up to the mark with the same solvent (Stock solution).Further pipette 0.3ml of the flupritine stock solution into a 10 ml volumetric flask and   dilute up to the mark with diluent. (Fig.3)

 

Figure 3 Click here to View figure

 

Preparation of Sample preparation

Accurately weigh and transfer equivalent to 10 mg of Tablet powder Fpmt Working standard into a10 mL volumetric flask add about 7 mL of Diluent and sonicated to dissolve it completely and made volume up to the mark with the same solvent (Stock solution).Further pipette 0.3 ml of the flupritine stock solution into a 10 ml volumetric flask and   dilute up to the mark with diluent. The % assay was found to be 100%.

VALIDATION OF THE METHOD

Validation of the optimized method was performed according to the ICH Q2 (B) guidelines^9-10.

SYSTEM SUITABILITY STUDIES

The system suitability test was carried out on freshly prepared stock solution of flupritine to check various parameters such as column efficiency, tailing factor and number of theoretical and presented in Table 1. The values obtained were demonstrated the suitability of the system for the analysis of the drug. System suitability parameter may fall within 2 % standard deviation range during routine performance of the method.

 

Table 1 Click here to View table

 

LINEARITY

For the HPLC method for the determination of linearity, prepared standard solution at five different concentration levels. The method was found to be linear in the range of 50 to 150% of target assay concentration i.e. 200 to 600 µg/ml. peak areas were recorded and calibration curve was plotted by plotting peak areas on y axis and concentration on x axis. The calibration curve was shown in fig.3and the results are presented in table 2.In UV the method was found to be linear in the range of 50 to 175 % of target assay concentration. I.e. 10 to 35 µg/ml   measured the absorbances of the above levels at 250nm Plotted a graph of peak area versus concentration (on X-axis concentration and on Y-axis Peak area) and calculate the correlation coefficient.The calibration curve was shown in fig.4 and the results are presented in table 3.

 

Figure 3B Click here to View figure

 

Table 2 Click here to View table

 

Figure 4 Click here to View figure

 

Table 3 Click here to View table

 

METHOD PRECISION (INTRA AND INTER DAY):

The repeatability of the analytical method under normal operational conditions was verified by injecting assay preparationssix times individually and calculated the % RSD. The same was performed on different day also. And the % RSD values for intraday and inter day precision were based on the mean and standard deviations. The % RSD was found to be less than 1% by UV and less than 2 % by HPLC, indicating that the method was sufficiently precise; the results are shown in table 4.

 

Table 4 Click here to View table

 

ACCURACY OR RECOVERY

Accuracy is the percent of the analyte recovered by assay from a known added amount. This study is mainly useful in order to check the accuracy of the developed method and to study the interference of the formulation additives. For the measurement of accuracy data from nine determinations over three concentration levels i.e. 50%, 100% and 150 % were determined. The results are presented in table 5.

 

Table 5 Click here to View table

 

ROBUSTNESS

Robustness of the method was verified by altering individually the chromatographic conditions like mobile phase composition (10%) , flow rate (±2 nm), column temperature (±5°C), etc.it was observed that no much variation in system suitability parameters even after these small delibral changes.These results proved that the developed method was robust.In UV method the wave length was varied at 248 nm to 252nm. On evaluation of the above results, it can be concluded that the variation in wave length affected the method significantly. Hence it indicates that the method is robust even by change in the wave length.

FORCED DEGRADATION STUDIES

The International Conference on Harmonization (ICH) guideline entitled stability testing of new drug substances and products requires that stress testing be carried out to elucidate the inherent stability characteristics of the active substance. The aim of this work was to perform the stress degradation studies on theflupritine using the proposed methodForced degradation of the flupritine maleate drug substance was performed under acid, alkaline, peroxide, thermal, photolytic and hydrolysis stress conditions. The procedure and results were summarized in the table 6& 7.

TABLE 6: SUMMARY OF DEGRADATION STUDIES BYHPLC

Mode of degradation	Conditions	Assay (mg/tablet)	FLUPRITINE MALEATE
			%Degradation w.r.t. control	Purity angle	Purity Threshold
Control	No treatment	398.2	–	–	–
Acid degradation 5N  HCl	40°C/5min	369.2	7.30	0.131	0.289
Alkali degradation 1N NaOH	80°C/1hr	360.76	9.40	0.153	0.293
Peroxide degradation 30%W/V H2O2	80°C/10min	293.76	26.20	0.209	0.296
Thermal degradation	105°C/72hrs	376.32	5.50	0.195	0.306
Photolytic degradation	UV/72hrs	331.56	16.70	0.176	0.304
Humidity degradation	25°C/90%RH/ 72 hrs	395.08	0.80	0.146	0.289

 

Table 7 Click here to View table

 

RESULTS AND DISCUSSION

The developed methods for estimation of flupritine maleate were found to be accurate, simple and precise. The simplicity and ease of the developed methods lie in using Methanol as solvent.

The linearity of both HPLC and UV methods showed excellent correlation coefficient of 0.999.

In precision studythe% RSD was found to be less than 1% by UV and less than 2 % by HPLC, indicating that the method was sufficiently precise. Both methods showed good recovery and the recovery values are found between 98 to 101 % and % RSD was found to be less than 1% indicating accuracy of the method. The method was found to be robust because system suitability was passed even though deliberal changes were made in the developed HPLC and UV methods. In degradation studies it was observed that purity threshold value greater than the purity angle in each condition value it indicates the noninterference of the excipients, degradants with the analyte peak.

CONCLUSION

The developed methods are able to analyze the commercial formulations economically.

REFERENCES

1. Devulder J. Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs. 2010; 24(10):867-881.
2. Neil OJM. The Merck Index, an Encyclopedia of Chemicals Drug and Biologicals,. Eds, 14th Edn., Merck Research Laboratories, Division of Merck and Co. Inc., White House Station, NJ. 2006:717.
3. Shah U, Kavad M and Raval M. Development and validation of UV spectrophotometric method for estimation of Paracetamol and Flupirtine maleate in bulk and pharmaceutical dosage form. International Journal of Pharm Tech Research. 2013; 5(3):1007-1013.
4. Amal Dand Aneesh TP. Method development and validation for the estimation of Flupirtine maleate in bulk and pharmaceutical dosage form by UV spectrophotometry. International Research Journal of Pharmacy. 2011;2(12):179-182.
5. Zhang D, Song X and Su J. Isolation, identification and characterization of novel process-related impurities in Flupirtine maleate. Journal of Pharmaceutical and Biomedical Analysis.2014; 90:27-34.
6.  Lalitha KV, Murali Mohan G, Ravindra Reddy J, Vinod Kumar K and Alekhya A. RP-HPLC method development and validation for the simultaneous estimation of Paracetamol and Flupirtine maleate in pharmaceutical dosage. Journal of Scientific and Innovative Research. 2013; 2(3):634-641.
7. Wang H, Zhang Y and Nie L. Determination of Flupirtine maleate capsules by RP-HPLC. Qilu Pharmaceutical Affairs.2010; 10:23-25.
8. B. Mohan Gandhi, A. Lakshmana Rao and J. Venkateswara Rao a novel stability indicating rp-hplc method for the estimation of flupirtine in pharmaceutical dosage forms. International journal of pharmaceutical, chemical and biological sciences2014, 4(2), 208-218.
9. ICH Harmonised Tripartite Guideline, Validation of analytical procedures: Text and methodology, Q2 (R1), International Conference on Harmonization. 2005:1-13.
10. ICH Harmonised Tripartite Guideline, Stability Testing of New Drug Substances and Products, Q1A (R2), International Conference on Harmonization.2003:1-18.

---

This work is licensed under a Creative Commons Attribution 4.0 International License.